Open Access
| Issue |
Med Sci (Paris)
Volume 38, Number 10, Octobre 2022
|
|
|---|---|---|
| Page(s) | 772 - 775 | |
| Section | Nouvelles | |
| DOI | https://doi.org/10.1051/medsci/2022121 | |
| Published online | 11 October 2022 | |
- Yau C, Osdoit M, van der Noordaa M, et al. Residual cancer burden after neoadjuvant chemotherapy and long-term survival outcomes in breast cancer: a multicentre pooled analysis of 5 161 patients. Lancet Oncol 2022; 23 : 149–60. [CrossRef] [PubMed] [Google Scholar]
- Kuett L, Catena R, Ozcan A, et al. Three-dimensional imaging mass cytometry for highly multiplexed molecular and cellular mapping of tissues and the tumor microenvironment. Nat Cancer 2022; 3 : 122–33. [CrossRef] [PubMed] [Google Scholar]
- Ali HR, Dariush A, Provenzano E, et al. Computational pathology of pre-treatment biopsies identifies lymphocyte density as a predictor of response to neoadjuvant chemotherapy in breast cancer. Breast Cancer Res 2016 ; 18 : 21. [CrossRef] [PubMed] [Google Scholar]
- Galon J, Costes A, Sanchez-Cabo F, et al. Type, density, and location of immune cells within human colorectal tumors predict clinical outcome. Science 2006 ; 313 : 1960–1964. [Google Scholar]
- Zhang L, Conejo-Garcia JR, Katsaros D, et al. Intratumoral T cells, recurrence, and survival in epithelial ovarian cancer. N Engl J Med 2003 ; 348 : 203–213. [CrossRef] [PubMed] [Google Scholar]
- Green DR, Ferguson T, Zitvogel L, Kroemer G. Immunogenic and tolerogenic cell death. Nat Rev Immunol 2009 ; 9 : 353–363. [CrossRef] [PubMed] [Google Scholar]
- Dieu-Nosjean MC, Antoine M, Danel C, et al. Long-term survival for patients with non-small-cell lung cancer with intratumoral lymphoid structures. J Clin Oncol 2008 ; 26 : 4410–4417. [CrossRef] [PubMed] [Google Scholar]
- Binnewies M, Pollack JL, Rudolph J, et al. Targeting TREM2 on tumor-associated macrophages enhances immunotherapy. Cell Rep 2021; 37 : 109844. [CrossRef] [PubMed] [Google Scholar]
- Huang TX, Tan XY, Huang HS, et al. Targeting cancer-associated fibroblast-secreted WNT2 restores dendritic cell-mediated antitumour immunity. Gut 2022; 71 : 333–44. [CrossRef] [PubMed] [Google Scholar]
- Bassez A, Vos H, Van Dyck L, et al. A single-cell map of intratumoral changes during anti-PD1 treatment of patients with breast cancer. Nat Med 2021; 27 : 820–32. [CrossRef] [PubMed] [Google Scholar]
- Nagasaki J, Inozume T, Sax N, et al. PD-1 blockade therapy promotes infiltration of tumor-attacking exhausted T cell clonotypes. Cell Rep 2022; 38 : 110331. [CrossRef] [PubMed] [Google Scholar]
- Liu B, Hu X, Feng K, et al. Temporal single-cell tracing reveals clonal revival and expansion of precursor exhausted T cells during anti-PD-1 therapy in lung cancer. Nat Cancer 2022; 3 : 108–21. [CrossRef] [PubMed] [Google Scholar]
Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.
Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.
Initial download of the metrics may take a while.